Update on the use of Trandolapril in the management of cardiovascular disorders
Ariel Diaz1, Anique Ducharme21University of Montreal, Trois-Rivieres; 2Department of Medicine, Montreal Heart Institute Research Center, Montreal, Quebec, CanadaAbstract: Trandolapril is a well known angiotensin converting enzyme (ACE) inhibitor with many cardiovascular (CV) indications. The objecti...
Main Authors: | Ariel Diaz, Anique Ducharme |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-12-01
|
Series: | Vascular Health and Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/update-on-the-use-of-trandolapril-in-the-management-of-cardiovascular--peer-reviewed-article-VHRM |
Similar Items
-
SUPPRESSION OF RENIN-ANGIOTENSIN SYSTEM TO PREVENT COMPLICATIONS OF CARDIOVASCULAR DISEASES: CURRENT "ROLES" DISTRIBUTION FROM CLINICAL PHARMACOLOGIST’S POINT OF VIEW
by: S. R. Gilyarevskiy, et al.
Published: (2016-01-01) -
Brazilian multicenter study on efficacy and tolerability of trandolapril in mild-to-moderate essential arterial hypertension. EMBATHE substudy with ambulatory blood pressure monitoring
by: Osvaldo Kohlmann Jr, et al.
Published: (1999-05-01) -
HPTLC METHOD DEVELOPMENT AND VALIDATION OF TRANDOLAPRIL IN BULK AND PHARMACEUTICAL DOSAGE FORMS
by: N. Sreekanth, et al.
Published: (2010-06-01) -
HPTLC method development and validation of trandolapril in bulk and pharmaceutical dosage forms
by: N Sreekanth, et al.
Published: (2010-01-01) -
The Effect of Trandolapril on Insulin Resistance is Determined by the Degree of Baseline Resistance Level
by: Canan Ersoy, et al.
Published: (2014-06-01)